Practical pituitary pathology: what does the pathologist need to know?
SL Asa - Archives of pathology & laboratory medicine, 2008 - meridian.allenpress.com
Context.—The sellar region is the site of frequent pathology. The pituitary is affected by a
large number of pathologic entities arising from the gland itself and from adjacent …
large number of pathologic entities arising from the gland itself and from adjacent …
[HTML][HTML] Advances in understanding pituitary tumors
A Kopczak, U Renner, GK Stalla - F1000prime reports, 2014 - ncbi.nlm.nih.gov
Pituitary tumors are common in the general population. Since neuroimaging techniques
have improved, pituitary tumors are more often diagnosed incidentally. About 16.7% of the …
have improved, pituitary tumors are more often diagnosed incidentally. About 16.7% of the …
[HTML][HTML] Non-functioning pituitary adenomas
JB Drummond, A Ribeiro-Oliveira Jr… - Endotext [Internet], 2022 - ncbi.nlm.nih.gov
ABSTRACT Pituitary adenomas comprise approximately 10-20% of intracranial tumors. Non-
functioning pituitary adenomas (NFPAs) are benign adenohypophyseal tumors not …
functioning pituitary adenomas (NFPAs) are benign adenohypophyseal tumors not …
Classification and pathology of pituitary tumors
G Kontogeorgos - Endocrine, 2005 - Springer
Pituitary adenomas originating in adenohypophysial cells represent the most common
neoplasms of the sella turcica. The pathologist's goal is the optimal diagnosis and …
neoplasms of the sella turcica. The pathologist's goal is the optimal diagnosis and …
The pathogenesis of pituitary tumors
Recently there has been significant progress in our understanding of pituitary development,
physiology, and pathology. New information has helped to clarify the classification of …
physiology, and pathology. New information has helped to clarify the classification of …
[HTML][HTML] Current and emerging medical therapies in pituitary tumors
N Sahakian, F Castinetti, T Brue, T Cuny - Journal of clinical medicine, 2022 - mdpi.com
Pituitary tumors (PT) represent in, the majority of cases, benign tumors for which surgical
treatment still remains, except for prolactin-secreting PT, the first-line therapeutic option …
treatment still remains, except for prolactin-secreting PT, the first-line therapeutic option …
Marked response of a hypermutated ACTH-secreting pituitary carcinoma to ipilimumab and nivolumab
Context Pituitary carcinoma is a rare and aggressive malignancy with a poor prognosis and
few effective treatment options. Case A 35-year-old woman presented with an aggressive …
few effective treatment options. Case A 35-year-old woman presented with an aggressive …
[HTML][HTML] From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
The classification of neoplasms of adenohypophysial cells is misleading because of the
simplistic distinction between adenoma and carcinoma, based solely on metastatic spread …
simplistic distinction between adenoma and carcinoma, based solely on metastatic spread …
[HTML][HTML] The epidemiology of aggressive pituitary tumors (and its challenges)
OM Dekkers, N Karavitaki, AM Pereira - Reviews in Endocrine and …, 2020 - Springer
Pituitary tumors are not rare if prevalence rates from autopsy or radiological series are
considered; approximately 0.5% of all pituitary adenomas will come to medical attention …
considered; approximately 0.5% of all pituitary adenomas will come to medical attention …
[HTML][HTML] The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs)
MP Yavropoulou, M Tsoli, K Barkas… - Endocrine-Related …, 2020 - erc.bioscientifica.com
Non-functioning pituitary adenomas, recently alternatively termed pituitary neuroendocrine
tumours (NFpitNETs), are mostly benign neoplasms that are not associated with a hormonal …
tumours (NFpitNETs), are mostly benign neoplasms that are not associated with a hormonal …